Vemurafenib in Metastatic Melanoma - Mechanism and Resistance

ReachableAsh avatar
ReachableAsh
·
·
Download

Start Quiz

Study Flashcards

8 Questions

What is the main role of PARP in DNA repair?

Enabling repair of DNA damage caused by alkylating agents

How do PARP inhibitors work in cancer treatment?

By inhibiting PARP from repairing DNA damage

What is the specific weakness in BRCA mutated tumor cells that PARP inhibitors target?

Inability to repair DNA damage

How do BRCA1 and BRCA2 genes contribute to cancer development?

By enhancing DNA repair mechanisms

What happens if the BRCA system is mutated?

Cell death due to lack of repair

Why is the use of PARP inhibitors significant in breast cancer treatment?

To target BRCA mutated tumor cells

Which type of DNA breaks are associated with BRCA gene function?

Double-stranded DNA breaks

In the context of mutations, what effect do KRAS mutations have on metastatic colorectal cancer (mCRC)?

Lead to resistance to targeted therapies

Explore the mechanism of action of Vemurafenib in inhibiting BRAFV600E kinase, leading to the blockade of cell proliferation. Learn about the efficacy of BRAF inhibition in treating metastatic melanoma, the development of resistance over time, and the combination therapy with MEK inhibitors.

Make Your Own Quizzes and Flashcards

Convert your notes into interactive study material.

Get started for free
Use Quizgecko on...
Browser
Browser